medical devices

Blue Note Therapeutics raises $26M to help treat cancer-related distress via cognitive behavioral stress management (CBSM)

by

Blue Note Ther­a­peu­tics Rais­es $26.25 Mil­lion in Series A Financ­ing (press release):

Blue Note Ther­a­peu­tics, Inc., today announced the clos­ing of a Series A financ­ing round of $26.25 mil­lion. Pro­ceeds will allow the com­pa­ny to scale the orga­ni­za­tion and fund near-term clin­i­cal tri­als of its lead pre­scrip­tion dig­i­tal ther­a­peu­tic (PDT), which will poten­tial­ly improve the treat­ment of can­cer. The cap­i­tal will also sup­port the devel­op­ment of Blue Note’s pipeline assets. The Series A financ­ing was led by JAZZ Ven­ture Part­ners and joined by Sum­mer VC. [Read more…] about Blue Note Ther­a­peu­tics rais­es $26M to help treat can­cer-relat­ed dis­tress via cog­ni­tive behav­ioral stress man­age­ment (CBSM)

The FDA warns consumers not to use unapproved apps and devices to diagnose concussion

by

_______

FDA warns pub­lic not to use unap­proved or uncleared med­ical devices to help assess or diag­nose a con­cus­sion (news release):

Today, the U.S. Food and Drug Admin­is­tra­tion is warn­ing the pub­lic not to use med­ical devices mar­ket­ed to con­sumers that claim to help assess, diag­nose or man­age head injury, includ­ing con­cus­sion, trau­mat­ic brain injury (TBI) or mild TBI. [Read more…] about The FDA warns con­sumers not to use unap­proved apps and devices to diag­nose concussion

Explore the latest in cognitive remediation and addressing learning disabilities

by

Dur­ing Expo Day select­ed Sum­mit Part­ners and Spon­sors show­cased their lat­est ini­tia­tives and solutions.

  • Franck Tarpin-Bernard, Man­ag­ing Direc­tor of Sci­en­tif­ic Brain Train­ing (SBT), dis­cussed new part­ner­ships fol­low­ing their ISO 13485 cer­ti­fi­ca­tion for med­ical devices — cog­ni­tive remediation.
  • Jes­si­ca Poulin, Strate­gic Oper­a­tions Man­ag­er at the Arrow­smith Pro­gram, pre­sent­ed plans to bet­ter equip 100+ schools help­ing stu­dents with spe­cial needs.

These pre­sen­ta­tions took place at the 2016 Sharp­Brains Vir­tu­al Sum­mit: Rein­vent­ing Brain Health in the Dig­i­tal Age (Decem­ber 6–8th, 2016).